Stay updated on Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page
- Check3 days agoChange DetectedA dedicated Locations section has been added and site listings updated to include California, Florida, Ohio, Texas, and Ontario. The previous per-location subsections were removed and the page revision updated to v3.3.3.SummaryDifference0.6%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this is a minor metadata update with no changes to the study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the site-wide notice about potential delays due to a lapse in government funding. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedNo additions or deletions were detected on the page; the visible content appears unchanged.SummaryDifference0.4%

- Check82 days agoChange Detected- Updated operating status notice and new version tag (v3.2.0) replacing v3.1.0. The page now informs users about potential delays due to funding and directs to official sources for status; previous version marker v3.1.0 was removed.SummaryDifference3%

- Check89 days agoChange DetectedAdded revision: v3.1.0; removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and an older revision tag v3.0.2.SummaryDifference0.4%

Stay in the know with updates to Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page.